Cargando…

Application of Animal Models in Diabetic Cardiomyopathy

Diabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wang-Soo, Kim, Jaetaek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024147/ https://www.ncbi.nlm.nih.gov/pubmed/33813812 http://dx.doi.org/10.4093/dmj.2020.0285

Ejemplares similares

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions
por: Lee, Wang-Soo, et al.
Publicado: (2015)

Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases
por: Lee, Wang-Soo, et al.
Publicado: (2021)

Modelling Diabetic Cardiomyopathy: Using Human Stem Cell-Derived Cardiomyocytes to Complement Animal Models
por: Purnama, Ujang, et al.
Publicado: (2022)

The Effects of Green Tea on Obesity and Type 2 Diabetes
por: Kim, Hyun Min, et al.
Publicado: (2013)

Nutritional Status and Cardiac Autophagy
por: Ahn, Jihyun, et al.
Publicado: (2013)

Letter: Higher Glycated Hemoglobin Level Is Associated with Increased Risk of Ischemic Stroke in Non-Diabetic Korean Male Adults (Diabetes Metab J 2011;35:551-7)
por: Lee, Seok Hong, et al.
Publicado: (2012)

Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals
por: Duong, Tam, et al.
Publicado: (2014)

Genetic Animal Models for Arrhythmogenic Cardiomyopathy
por: Gerull, Brenda, et al.
Publicado: (2020)

Updating Experimental Models of Diabetic Cardiomyopathy
por: Fuentes-Antrás, J., et al.
Publicado: (2015)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Using Zebrafish Animal Model to Study the Genetic Underpinning and Mechanism of Arrhythmogenic Cardiomyopathy
por: Niu, Yujuan, et al.
Publicado: (2023)

Of mice and men: models and mechanisms of diabetic cardiomyopathy
por: Riehle, Christian, et al.
Publicado: (2018)

The Impact of Fine Particulate Matter 2.5 on the Cardiovascular System: A Review of the Invisible Killer
por: Basith, Shaherin, et al.
Publicado: (2022)

Restrictive Cardiomyopathy Caused by Troponin Mutations: Application of Disease Animal Models in Translational Studies
por: Liu, Xiaoyan, et al.
Publicado: (2016)

Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
por: Leerink, Jan M., et al.
Publicado: (2021)

Diabetic cardiomyopathy
por: Asghar, Omar, et al.
Publicado: (2009)

Perception of Risk of Developing Diabetes in Offspring of Type 2 Diabetic Patients
por: Kim, Jaetaek, et al.
Publicado: (2002)

Risk of hospitalization for hypoglycemia among older Korean people with diabetes mellitus: Interactions between treatment modalities and comorbidities
por: Kim, Hyun Min, et al.
Publicado: (2016)

Insights into restrictive cardiomyopathy from clinical and animal studies
por: Jean-Charles, Pierre-Yves, et al.
Publicado: (2011)

Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia
por: Kim, Hyun Min, et al.
Publicado: (2017)

Breast cancer animal models and applications
por: Zeng, Li, et al.
Publicado: (2020)

CD36 Signaling in Diabetic Cardiomyopathy
por: Zhang, Xudong, et al.
Publicado: (2021)

Cardiomyocyte Specific Deletion of Crif1 Causes Mitochondrial Cardiomyopathy in Mice
por: Shin, Juhee, et al.
Publicado: (2013)

Predictors and prevention of diabetic cardiomyopathy
por: Chavali, Vishalakshi, et al.
Publicado: (2013)

Diagnostic approaches for diabetic cardiomyopathy
por: Lorenzo-Almorós, A., et al.
Publicado: (2017)

Mitochondrial Mechanisms in Diabetic Cardiomyopathy
por: Gollmer, Johannes, et al.
Publicado: (2020)

Role of inflammation in diabetic cardiomyopathy
por: Ramesh, Pranav, et al.
Publicado: (2022)

Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
por: Hölscher, Maximilian E., et al.
Publicado: (2016)

Efficacy of traditional Chinese medicine on diabetic cardiomyopathy in animal models: a systematic review and meta-analysis
por: Hu, Longxiao, et al.
Publicado: (2023)

Cellular environment of TTR deposits in an animal model of ATTR—Cardiomyopathy
por: Teixeira, Cristina, et al.
Publicado: (2023)

Role of histone deacetylase inhibitors in diabetic cardiomyopathy in experimental models (Review)
por: Garmpi, Anna, et al.
Publicado: (2022)

Animal models of enterovirus 71 infection: applications and limitations
por: Wang, Ya-Fang, et al.
Publicado: (2014)

MON-672 Progesterone Receptor Membrane Component 1 Suppresses Lipid Accumulation and Lipotoxicity in Animal Model of Diabetic Cardiomyopathy (DCM)
por: Lee, Sang R, et al.
Publicado: (2020)

Subcellular microRNAs in diabetic cardiomyopathy
por: Li, Huaping, et al.
Publicado: (2020)

Efficacy of Stem Cell Therapy in Large Animal Models of Ischemic Cardiomyopathies: A Systematic Review and Meta-Analysis
por: La Mantia, Debora, et al.
Publicado: (2022)

The Role of Mitochondrial Biogenesis Dysfunction in Diabetic Cardiomyopathy
por: Tao, Li-Chan, et al.
Publicado: (2022)

Exercise as A Potential Therapeutic Target for Diabetic Cardiomyopathy: Insight into the Underlying Mechanisms
por: Seo, Dae Yun, et al.
Publicado: (2019)

Evidence for human diabetic cardiomyopathy
por: Marfella, Raffaele, et al.
Publicado: (2021)

Role of novel biomarkers in diabetic cardiomyopathy
por: Kumric, Marko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8nh8qgq1f956rv7uvi7ut19mav